Friday, July 10, 2026

Drug profile · INN

fosamprenavir

fosamprenavir (TELZIR) is an FDA-listed pharmaceutical active ingredient.

EMA: withdrawn Antiinfectives for systemic use (J05) J05AE07
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — fosamprenavir
Class
Antiinfectives for systemic use (J05)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

fosamprenavir (TELZIR) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN fosamprenavir
Brand TELZIR
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AE07

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. 103900 Approved · Disc Medicine · HIV-infected

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is fosamprenavir?

fosamprenavir (TELZIR) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for fosamprenavir?

TELZIR is a marketed brand name for fosamprenavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.